ROIV ROIVANT SCIENCES LTD Investor Conferences 8-K Filing 2024 - Graves Disease Update Roivant Sciences Ltd. provided an update on the Graves Disease development program at Immunovant through a press release on September 9, 2024.Get access to all SEC 8-K filings of the ROIVANT SCIENCES LTD